M · D · E
Morgan D. Elwyn~~Ziyad H. Aziz~~Timothy F. Sullivan~~Patrais Strzelecki
January 24, 2026
Willkie Advises PharmaCord on Investment from Permira

1 min
AI-made summary
- PharmaCord LLC, a provider of patient services for the pharmaceutical industry, has received a substantial investment from global investment firm Permira
- On June 6, Permira and PharmaCord announced that a Permira-backed company signed a definitive agreement to invest in PharmaCord, which partners with life sciences organizations for commercialization
- Willkie advised PharmaCord on the transaction, with a team led by partners Morgan Elwyn and Ziyad Aziz.
Willkie advised PharmaCord LLC, a leading provider of patient services for the pharmaceutical industry, in connection with a substantial investment from global investment firm Permira.
On June 6, Permira and PharmaCord announced that a company backed by the Permira funds signed a definitive agreement to make a substantial investment in PharmaCord, a high-growth pharma services company that serves as a commercialization partner for life sciences organizations. The Willkie team was led by partners Morgan Elwyn and Ziyad Aziz and included associates Timothy Sullivan, Steven Mikel, Orlando He and Patrais Strzelecki.
M
Article Author
Morgan D. Elwyn~~Ziyad H. Aziz~~Timothy F. Sullivan~~Patrais Strzelecki
The Sponsor
